The combination of metoclopramide, methylprednisolone and ondansetron against antiblastic-delayed emesis: a randomised phase II study.

Abstract

The aim of the study was to verify whether the combination of an antiserotoninergic, metoclopramide, and a steroid could improve the complete control (CC) of delayed emesis, a contraversial issue, 105 patients undergoing highly-emetogenic chemotherapy, receiving Ondansetron (O) 8 mg + Dexamethasone 20 mg i.v. for the prevention of acute emesis, were… (More)

Topics

Cite this paper

@article{Mustacchi1997TheCO, title={The combination of metoclopramide, methylprednisolone and ondansetron against antiblastic-delayed emesis: a randomised phase II study.}, author={Giorgio Mustacchi and Rita Ceccherini and M L Leita and Prashanth Sandri and Shirin Milani and Teresa Carbonara}, journal={Anticancer research}, year={1997}, volume={17 2B}, pages={1345-8} }